Staphylococcus aureus (NORTHCENTRAL Data) | |||||||
2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
penicillin | 16.4% n=1278 | 10.7% n=708 | 18.9% n=428 | 19.5% n=467 | 20.9% n=512 | 20.2% n=1005 | |
amoxicillin/clavulanate | 54.1% n=455 | 51% n=465 | 40% n=542 | 78% n=254 | 99.1% n=214 | ||
ampicillin | 14.1% n=455 | 9% n=465 | 6.1% n=542 | 11.8% n=254 | 18.2% n=214 | ||
ampicillin/sulbactam | 58% n=455 | 51% n=465 | |||||
nafcillin/oxacillin | 58.8% n=1278 | 67.8% n=708 | |||||
vancomycin | 100% n=1278 | 100% n=708 | 100% n=249 | 100% n=1009 | 100% n=766 | 100% n=1219 | |
quinupristin/dalfopristin | 99.1% n=542 | 100% n=254 | 100% n=214 | ||||
cefazolin | 58.8% n=1278 | 67.8% n=708 | 100% n=249 | 99.2% n=249 | 100% n=198 | ||
cephalothin | 50.1% n=455 | ||||||
ceftriaxone | 100% n=245 | 1.1% n=465 | 99% n=512 | ||||
clindamycin | 64.6% n=1278 | 60.2% n=708 | 76.6% n=428 | 77.3% n=467 | 78.3% n=755 | 78.3% n=1219 | |
erythromycin | 57.4% n=700 | 46% n=708 | 72.7% n=428 | 75.2% n=467 | 73% n=512 | 71.8% n=1005 | |
ciprofloxacin | 49% n=455 | 54% n=465 | |||||
ofloxacin | 100% n=249 | ||||||
levofloxacin | 66.7% n=700 | 66% n=708 | 78% n=428 | 72.7% n=1009 | 77.9% n=766 | 95.4% n=1219 | |
gatifloxacin | 65.1% n=455 | 66% n=465 | |||||
TMP/SMX | 98.3% n=1278 | 98.4% n=708 | 95.3% n=428 | 98.3% n=1009 | 98.3% n=766 | 96.4% n=1218 | |
tetracycline | 95.9% n=542 | 96.3% n=766 | 96.6% n=1219 | ||||
gentamicin | 94.9% n=455 | 94% n=465 | 99.1% n=542 | 98.8% n=254 | 90.3% n=1021 | ||
imipenem | 50.1% n=455 | 40% n=542 | 78% n=254 | 0% n=214 | |||
pip/taz | 100% n=218 | 99% n=197 | 99.1% n=214 | ||||
rifampim | 98% n=455 | 97% n=465 | |||||
Totals | 64.2% n=13408 | 60% n=9384 | 76.5% n=2887 | 74.4% n=8147 | 81.5% n=6822 | 80.9% n=10393 |
This data is accurate as of: 11/22/2016 11:53:46 AM
Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: .